Evidence map›Paper›PMID 33230120›Full record

ArticleNature communications2020

Epidemiology and biology of a herpesvirus in rabies endemic vampire bat populations.

Megan E Griffiths, Laura M Bergner, Alice Broos, Diana K Meza, Ana da Silva Filipe, Andrew Davison, Carlos Tello, Daniel J Becker, Daniel G Streicker

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Inferring the disruption of rabies circulation in vampire bat populations using a betaherpesvirus-vectored transmissible vaccine.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Quantifying the effectiveness of betaherpesvirus-vectored transmissible vaccines.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Megan E GriffithsMRC-University of Glasgow Centre for Virus Research, Glasgow, UK. m.griffiths.1@research.gla.ac.uk.ORCID 0000-0003-4130-9840
Laura M BergnerMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID 0000-0003-4169-7169
Alice BroosMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID 0000-0001-7593-1000
Diana K MezaMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Ana da Silva FilipeMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID 0000-0002-9442-2903
Andrew DavisonMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID 0000-0002-4991-9128
Carlos TelloAssociation for the Conservation and Development of Natural Resources, Lima, Perú.
Daniel J BeckerDepartment of Biology, Indiana University, Bloomington, IN, USA.
Daniel G StreickerMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID 0000-0001-7475-2705
MRC University of Glasgow Centre for Virus Research · GBIndiana University Bloomington · USYunkawasi · PE

Funding

Medical Research Council MC_UU_12014/12Medical Research Council MC_UU_12014/3Wellcome TrustWellcome Trust 102507/Z/13/ZWellcome Trust 217221/Z/19/Z
6 · The paper itself

Abstract

Rabies is a viral zoonosis transmitted by vampire bats across Latin America. Substantial public health and agricultural burdens remain, despite decades of bats culls and livestock vaccinations. Virally vectored vaccines that spread autonomously through bat populations are a theoretically appealing solution to managing rabies in its reservoir host. We investigate the biological and epidemiological suitability of a vampire bat betaherpesvirus (DrBHV) to act as a vaccine vector. In 25 sites across Peru with serological and/or molecular evidence of rabies circulation, DrBHV infects 80-100% of bats, suggesting potential for high population-level vaccine coverage. Phylogenetic analysis reveals host specificity within neotropical bats, limiting risks to non-target species. Finally, deep sequencing illustrates DrBHV super-infections in individual bats, implying that DrBHV-vectored vaccines might invade despite the highly prevalent wild-type virus. These results indicate DrBHV as a promising candidate vector for a transmissible rabies vaccine, and provide a framework to discover and evaluate candidate viral vectors for vaccines against bat-borne zoonoses.

Indexed as

AnimalsBetaherpesvirinaeBiological CoevolutionCattleChiropteraGenome, ViralHerpesviridae InfectionsHost SpecificityMammalsPeruPhylogenyRabiesRabies virusSeroepidemiologic StudiesSuperinfection

Identifiers

PMID33230120
PMCPMC7683562
OpenAlexW3107502220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.